King Khaled Eye Specialist Hospital, Riyadh, Kingdom of Saudi Arabia.
Department of Ophthalmology, College of Medicine, Princess Nourah Bint Abdulrahman University, Riyadh, Kingdom of Saudi Arabia.
Int Ophthalmol. 2021 Jan;41(1):349-362. doi: 10.1007/s10792-020-01575-2. Epub 2020 Sep 3.
Several studies have reported conflicting results on ocular manifestations and transmission of coronavirus disease 2019 (COVID-19) whose causative virus, SARS-CoV-2, belongs to the coronavirus family, the seventh recognized as a human pathogen and the third causing a severe clinical syndrome. COVID-19 primarily affects the lungs, similar to the other human coronaviruses. Comparing the relation between the animal-to-human transmitted coronaviruses (SARS-CoV-1, SARS-Cov-2, MERS-CoV, CoV-229E, NL63, OC43, HKU1) and the eye may contribute to determining their actual eye-tissue tropism and risk of ocular transmission.
Literature review was conducted via Pubmed.gov, Google Scholar and medRixv using the following keywords: COVID-19, SARS-CoV-2, SARS-CoV-1, MERS-CoV, CoV-229E, NL63, OC43, HKU1, conjunctivitis, tear swab, ocular expression, ocular symptoms and human angiotensin converting enzyme-2 expression. Studies with lack in methodology were excluded.
Sixteen observational studies were selected. The range for detection of viral RNA in tears was 0-8% for SARS-CoV-1 and 0-5.3% for SARS-CoV-2, while no reports were found for other coronaviruses. Ocular manifestations have been reported for NL63 and SARS-CoV-2. Ocular symptoms in the form of conjunctivitis/conjunctival congestion predominantly were detected in 65 (3.17%) out of 2048 reported patients with COVID-19 (range of 0.8-32%). Eye symptoms were not reported for the other coronaviruses.
Data aggregation for coronaviruses shows a relatively low eye-tissue tropism. Conjunctival congestion is an uncommon manifestation of COVID-19 similar to all human coronaviruses' infections. In a low percentage of patients, the virus can be excreted in ocular fluids at different stages of the infection, regardless of positive SARS-Cov-2 throat swab. Albeit high viral loads in ocular tissue seem to have relatively low prevalence, the eye should be regarded as a potential source of infection dissemination for COVID-19.
有几项研究报告了关于冠状病毒病 2019(COVID-19)的眼部表现和传播的相互矛盾的结果,其致病病毒 SARS-CoV-2 属于冠状病毒科,这是第七种被认定为人病原体,第三种引起严重临床综合征的病毒。COVID-19 主要影响肺部,与其他人类冠状病毒相似。比较动物源性冠状病毒(SARS-CoV-1、SARS-CoV-2、MERS-CoV、CoV-229E、NL63、OC43、HKU1)与眼睛之间的关系,有助于确定它们对眼组织的实际嗜性和眼部传播的风险。
通过 Pubmed.gov、Google Scholar 和 medRixv 利用以下关键词进行文献回顾:COVID-19、SARS-CoV-2、SARS-CoV-1、MERS-CoV、CoV-229E、NL63、OC43、HKU1、结膜炎、泪拭子、眼部表达、眼部症状和人类血管紧张素转换酶 2 表达。排除方法欠缺的研究。
选择了 16 项观察性研究。SARS-CoV-1 病毒 RNA 在泪液中的检测率为 0-8%,SARS-CoV-2 为 0-5.3%,而其他冠状病毒则没有报道。NL63 和 SARS-CoV-2 已有眼部表现的报道。以结膜炎/结膜充血为主的眼部症状在 2048 例 COVID-19 报告患者中,有 65 例(3.17%)(范围为 0.8-32%)。其他冠状病毒没有眼部症状的报道。
冠状病毒的数据汇总显示,其对眼组织的嗜性相对较低。结膜充血是 COVID-19 的一种不常见表现,与所有人类冠状病毒感染相似。在一小部分患者中,无论 SARS-CoV-2 咽喉拭子是否为阳性,病毒都可以在感染的不同阶段从眼部分泌物中排出。虽然眼部组织中的病毒载量较高,但患病率相对较低,但眼睛应被视为 COVID-19 传播的潜在感染源。